(Q43556129)

24 November 2017

title

National Surgical Adjuvant Breast and Bowel Project trials in colon cancer (English)

1 reference

24 November 2017

Wolmark N

1

1 reference

24 November 2017

Colangelo L

series ordinal

2

1 reference

24 November 2017

Wieand S

series ordinal

3

1 reference

24 November 2017

language of work or name

1 reference

1 February 2001

1 reference

24 November 2017

1 reference

24 November 2017

volume

28

1 reference

24 November 2017

issue

1 Suppl 1

1 reference

24 November 2017

page(s)

9-13

1 reference

Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990245-3

7 January 2021

Adjuvant cytotoxic liver perfusion for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990245-3

7 January 2021

Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990245-3

7 January 2021

The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990245-3

7 January 2021

Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990245-3

7 January 2021

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990245-3

7 January 2021

Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990245-3

7 January 2021

Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990245-3

7 January 2021

Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990245-3

7 January 2021

Phase II trial of fluorouracil and recombinant interferon alfa-2a in patients with advanced colorectal carcinoma: an Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990245-3

7 January 2021

Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05.

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990245-3

7 January 2021

Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990245-3

7 January 2021

A fixed-ratio combination of uracil and Ftorafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990245-3

7 January 2021

Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990245-3

7 January 2021

Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990245-3

7 January 2021

10.1016/S0093-7754(01)90245-3

Identifiers

DOI

1 reference

24 November 2017

1 reference